FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3206808049> ?p ?o ?g. }

• W3206808049 endingPage "841" @default.
• W3206808049 startingPage "834" @default.
• W3206808049 abstract "Purpose Little is known about the impact of financial toxicity in disease-free breast cancer survivors. We aim to validate the COmprehensive Score for financial Toxicity in Korean (COST-K) and evaluate financial toxicity among disease-free breast cancer survivors.Materials and Methods We conducted linguistic validation following a standardized methodology recommended by Functional Assessment of Chronic Illness Therapy multilingual translation (FACITtrans). For psychometric validation, we conducted a cross-sectional survey with 4,297 disease-free breast cancer survivors at a tertiary hospital in Seoul, Korea between November 2018 and April 2019. Survivors were asked to complete the COST-K and European Organization for Research and Treatment of Cancer Quality of Life Core 30 (EORTC QLQ-C30) questionnaires. The test-retest reliability, internal consistency, and validity of the COST-K were assessed using standard scale construction techniques.Results The COST-K demonstrated good internal consistency, with a Cronbach’s α of 0.81. The test-retest analysis revealed an intraclass correlation coefficient of 0.78. The COST-K had moderate correlation (r=–0.60) with the financial difficulty item of the EORTC QLQ-C30 and week correlation with the items on acute and chronic symptom burdens (nausea/vomiting, –0.18; constipation, –0.14; diarrhea, –0.14), showing good convergent and divergent validity. The median COST-K was 27 (range, 0 to 44; mean±standard deivation [SD], 27.1±7.5) and about 30% and 5% of cancer survivors experienced mild and severe financial toxicity, respectively. Younger age, lower education, lower household income was associated with higher financial toxicity.Conclusion The COST-K is a valid and reliable instrument for measuring financial toxicity in disease-free breast cancer survivors. Considering its impact on the health-related quality of life, more studies need to be conducted to evaluate financial toxicity in cancer survivors and design interventions." @default.
• W3206808049 created "2021-10-25" @default.
• W3206808049 creator A5012179152 @default.
• W3206808049 creator A5016487381 @default.
• W3206808049 creator A5022604964 @default.
• W3206808049 creator A5031863352 @default.
• W3206808049 creator A5031884534 @default.
• W3206808049 creator A5033852351 @default.
• W3206808049 creator A5038306641 @default.
• W3206808049 creator A5040692495 @default.
• W3206808049 creator A5055171803 @default.
• W3206808049 creator A5057636290 @default.
• W3206808049 creator A5059881624 @default.
• W3206808049 creator A5067521847 @default.
• W3206808049 creator A5068566980 @default.
• W3206808049 creator A5073109142 @default.
• W3206808049 creator A5076430510 @default.
• W3206808049 creator A5087363512 @default.
• W3206808049 date "2022-07-15" @default.
• W3206808049 modified "2023-10-02" @default.
• W3206808049 title "Validation of Korean Version of the COmprehensive Score for financial Toxicity (COST) Among Breast Cancer Survivors" @default.
• W3206808049 cites W1509760042 @default.
• W3206808049 cites W1598788265 @default.
• W3206808049 cites W1736453158 @default.
• W3206808049 cites W1969577451 @default.
• W3206808049 cites W1974739407 @default.
• W3206808049 cites W2040512988 @default.
• W3206808049 cites W2057622767 @default.
• W3206808049 cites W2088445683 @default.
• W3206808049 cites W2098919693 @default.
• W3206808049 cites W2099354636 @default.
• W3206808049 cites W2107038014 @default.
• W3206808049 cites W2109334536 @default.
• W3206808049 cites W2121508408 @default.
• W3206808049 cites W2134170718 @default.
• W3206808049 cites W2529430742 @default.
• W3206808049 cites W2533574559 @default.
• W3206808049 cites W2541721407 @default.
• W3206808049 cites W2587913380 @default.
• W3206808049 cites W2783091042 @default.
• W3206808049 cites W2788702857 @default.
• W3206808049 cites W2884888463 @default.
• W3206808049 cites W2890649314 @default.
• W3206808049 cites W2904112399 @default.
• W3206808049 cites W2911751302 @default.
• W3206808049 cites W2943077196 @default.
• W3206808049 cites W2955031832 @default.
• W3206808049 cites W2979609812 @default.
• W3206808049 cites W3178974784 @default.
• W3206808049 doi "https://doi.org/10.4143/crt.2021.784" @default.
• W3206808049 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34645130" @default.
• W3206808049 hasPublicationYear "2022" @default.
• W3206808049 type Work @default.
• W3206808049 sameAs 3206808049 @default.
• W3206808049 citedByCount "6" @default.
• W3206808049 countsByYear W32068080492023 @default.
• W3206808049 crossrefType "journal-article" @default.
• W3206808049 hasAuthorship W3206808049A5012179152 @default.
• W3206808049 hasAuthorship W3206808049A5016487381 @default.
• W3206808049 hasAuthorship W3206808049A5022604964 @default.
• W3206808049 hasAuthorship W3206808049A5031863352 @default.
• W3206808049 hasAuthorship W3206808049A5031884534 @default.
• W3206808049 hasAuthorship W3206808049A5033852351 @default.
• W3206808049 hasAuthorship W3206808049A5038306641 @default.
• W3206808049 hasAuthorship W3206808049A5040692495 @default.
• W3206808049 hasAuthorship W3206808049A5055171803 @default.
• W3206808049 hasAuthorship W3206808049A5057636290 @default.
• W3206808049 hasAuthorship W3206808049A5059881624 @default.
• W3206808049 hasAuthorship W3206808049A5067521847 @default.
• W3206808049 hasAuthorship W3206808049A5068566980 @default.
• W3206808049 hasAuthorship W3206808049A5073109142 @default.
• W3206808049 hasAuthorship W3206808049A5076430510 @default.
• W3206808049 hasAuthorship W3206808049A5087363512 @default.
• W3206808049 hasBestOaLocation W32068080491 @default.
• W3206808049 hasConcept C104709138 @default.
• W3206808049 hasConcept C106906290 @default.
• W3206808049 hasConcept C121608353 @default.
• W3206808049 hasConcept C126322002 @default.
• W3206808049 hasConcept C159110408 @default.
• W3206808049 hasConcept C171606756 @default.
• W3206808049 hasConcept C1862650 @default.
• W3206808049 hasConcept C2777319248 @default.
• W3206808049 hasConcept C2779951463 @default.
• W3206808049 hasConcept C530470458 @default.
• W3206808049 hasConcept C70410870 @default.
• W3206808049 hasConcept C71924100 @default.
• W3206808049 hasConceptScore W3206808049C104709138 @default.
• W3206808049 hasConceptScore W3206808049C106906290 @default.
• W3206808049 hasConceptScore W3206808049C121608353 @default.
• W3206808049 hasConceptScore W3206808049C126322002 @default.
• W3206808049 hasConceptScore W3206808049C159110408 @default.
• W3206808049 hasConceptScore W3206808049C171606756 @default.
• W3206808049 hasConceptScore W3206808049C1862650 @default.
• W3206808049 hasConceptScore W3206808049C2777319248 @default.
• W3206808049 hasConceptScore W3206808049C2779951463 @default.
• W3206808049 hasConceptScore W3206808049C530470458 @default.
• W3206808049 hasConceptScore W3206808049C70410870 @default.
• W3206808049 hasConceptScore W3206808049C71924100 @default.

• next